Awiqli® provides convenient once-weekly dosing1 Health Canada approval based on safety and efficacy data from the ONWARDS clinical trial program1 MISSISSAUGA, ON – Novo Nordisk is pleased to announce Canada… Read More
Application based on Phase 3 PALOMA-3 results showing five-fold reduction in infusion-related reactions with five-minute administration of subcutaneous amivantamab Longer overall survival, progression-free survival and duration of response also observed… Read More
Results from CLIMB-111, -121 and -131 accepted for oral presentation Data from these trials, with the longest follow-up of more than five years, demonstrate transformative, consistent and durable benefit of… Read More
Three researchers from the UBC Faculty of Medicine are among the new and renewed Canada Research Chairs recently announced by the Government of Canada. The Canada Research Chairs Program enables Canadian universities to… Read More
UBC Faculty of Medicine researchers have been awarded more than $6 million in federal funding from the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants program. A total of… Read More
